Pfizer settles with Novartis in Zithromax lawsuit

Share this article:

Pfizer has settled its lawsuit against Novartis for alleged infringement of the US patent for the antibiotic Zithromax (azithromycin), Bloomberg News reports.

Pfizer first sued Novartis and its Sandoz generics unit in February 2006 in federal court in Wilmington, DE.

Pfizer sought unspecified damages in the case, stating it would be “irreparably harmed” by Novartis’ use of a formulation of crystal azithromycin. Under the settlement, Pfizer and Novartis “have agreed to settle all claims” regarding the drug patent, court documents said.

The settlement is Pfizer’s second in a year related to the Zithromax patent. In November of 2006, Israel’s Teva Pharmaceutical Industries said it would pay Pfizer as much as $70 million for rights to make copies of Zithromax and cancer drug Idamycin.

Pfizer has seen sales of Zithromax nosedive as the other drugmakers, including American Pharmaceutical Partners, were able to bring their versions of azithromycin to market following the expiration of the drug’s US patent in 2005.

Branded Zithromax had $638 million in sales in 2006, down from $2 billion in 2005.

Share this article:

Email Newsletters

More in News

Star Group merges with Vox Medica, Calcium NYC

Star Group merges with Vox Medica, Calcium NYC

The newly formed group will be known as Calcium with Steve Michaelson, formerly of Rosetta Wishbone, at the helm.

Survey finds pay doesn't make doctors happy

Survey finds pay doesn't make doctors happy

Medscape's survey of over 24,000 physicians found that a paycheck is not necessarily linked to a physician's professional satisfaction.

CDC sees declines in some diabetes complications

CDC sees declines in some diabetes complications

Centers for Disease Control data shows that diabetes complications including heart attack and amputation fell in the twenty years between 1990 and 2010. The bad news: the number of diagnosed ...